Responses
Clinical and epidemiological research
Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 13 April 2016
- Published on: 13 April 2016Low-dose rituximab for SLEShow More
Dear Editor
We read with interest the article “Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythematosus” by Albert D. et al. (1) regarding the potential efficacy of rituximab administration in patients with lupus nephritis. Systemic lupus erythematosus (SLE) is a challenging disease associated to important and diverse immuno-regulatory alterations, including those of B and T c...
Conflict of Interest:
None declared.